Search Results

final prospectus supplement and the accompanying prospectus may be obtained on the SEC’s website at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

The paper can be accessed online at: https://pubmed.ncbi.nlm.nih.gov/38073274/. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses

The trial was a Multicenter (52 medical research centers/hospitals in 5 countries), randomized, double-blind (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Management will host a conference call on Thursday, August 9, 2018 at 4:30pm Eastern Time to review financial The conference call will also be available through a live webcast at http://www.wsw.com/webcast/cc/avxl6 (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

It is the second most common neurological disorder and approximately one million people in the United Fox Foundation is dedicated to accelerating a cure for Parkinson’s disease and improved therapies for (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated Barwicki Investor Relations Tel: 516-662-9461 Email: andrew@barwicki.com Media: Melyssa Weible Elixir Health Public Relations Tel: 201-723-5805 Email: mweible@elixirhealthpr.com [1] https://www.parkinson.org

“This is an important feature since OPCs can replace lost OLs by maturing into new potential myelin-producing The full paper can be accessed online at: (https://www.sciencedirect.com/science/article/abs/pii/S0165572819305831 (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

“There is such a significant unmet medical need around the globe caused by Alzheimer’s disease, Parkinson (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most

“Rett syndrome is a devastating, non-inherited genetic post-natal progressive neurodevelopmental disorder Management of symptoms is done through a multidisciplinary approach utilizing medication for motor difficulties (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Platform involves the rational design of drug compounds that fulfill specific criteria based on unmet medical Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866

including pediatric patients,” said Walter E Kaufmann, MD, Principal Investigator of the study and Chief Medical (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

announced that the Company has received approval from the Spanish Agency for Medicinal Products and Medical (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

Management will host a conference call on Thursday, August 12, 2021, at 4:30 pm EDT to review financial Webcast / Conference Call Information: The live webcast of the conference call can be accessed online at https (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most